BioDelivery Sciences International, Inc. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/352d0804-864a-4be0-ae64-285c388096fd/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $166.7M | 2021-01-01 – 2021-12-31 | evidence 0001103021-22-000051 |
| FY 2020 | $156.5M | 2020-01-01 – 2020-12-31 | evidence 0001103021-21-000029 |
| FY 2019 | $111.4M | 2019-01-01 – 2019-12-31 | evidence 0001103021-20-000042 |
| FY 2018 | $55.6M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-074893 |
| FY 2017 | $62.0M | 2017-01-01 – 2017-12-31 | evidence 0001193125-19-074893 |
| FY 2016 | $15.5M | 2016-01-01 – 2016-12-31 | evidence 0001193125-19-074893 |
| FY 2015 | $48.2M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-500290 |
| FY 2014 | $38.9M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-094062 |
| FY 2013 | $11.4M | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-094062 |
| FY 2012 | $54.5M | 2012-01-01 – 2012-12-31 | evidence 0001193125-15-094062 |
| FY 2011 | $3.3M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-121522 |
| FY 2010 | $3.4M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-121522 |
| FY 2009 | $62.8M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-121522 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
BioDelivery Sciences International, Inc. — all facts · Net Income · Operating Income